Shares of EverQuote tumbled 11.2% to $21.41 after the online insurance marketplace delivered a second quarter that topped Wall Street on every headline metric — then offered forward guidance that spooked investors. Revenue hit $195.1 million versus analyst estimates of $190.2 million, EPS came in at $0.53 versus $0.52, and adjusted EBITDA of $30.1 million beat the $29.09 million consensus. The stock's slide points to a market no longer willing to pay for rearview-mirror wins when the road ahead looks bumpier.
• Q3 Guidance Barely Nudged Past Expectations, and That Was Enough to Punish the Stock. The third-quarter revenue outlook has a midpoint of approximately $203 million, only slightly above the $201.7 million consensus estimate. Investors may have wanted a larger forecast beat or stronger earnings guidance.
Management guided Q3 revenue to $198 million–$208 million, representing just 17% year-over-year growth at the midpoint — a meaningful deceleration from Q2's 25% clip. For a stock that had already run from the low-$20s to near $27 in late July, a "meet, not beat" outlook gave profit-takers their cue.
• Growth Is Slowing and the Market Is Already Pricing That In. Sell-side analysts expect revenue to grow just 10.3% over the next 12 months, a deceleration versus the last three years.
Management acknowledged that new AI-first products under development are not expected to contribute material revenue this year, as the company is still in a testing phase. That means the near-term growth engine remains the core insurance-referral marketplace, which is maturing.
• The Profitability Story Is Solid but Not Accelerating Fast Enough. Adjusted EBITDA — a measure of operating profit before certain non-cash charges — grew 37% to $30.1 million, and the margin rose 1.4 percentage points to 15.4%. Yet free cash flow came in at $22.76 million, an 11.7% margin that was 3.6 percentage points lower than the same quarter last year. Investors watching cash generation — the money actually available after all bills are paid — saw a step backward.
• Analysts Still See Upside, But the Stock Has a History of Post-Earnings Drops. Needham raised its price target from $25 to $30, while B. Riley lifted its target from $30 to $34, both maintaining "buy" ratings. Yet earnings-date announcements for EverQuote have historically been followed by share-price declines, averaging -8.91%. The pattern suggests the market chronically reprices this stock when hopes meet reality — and today's drop, though sharper than average, fits the mold.